JAFL
BMY icon

Jay A. Fishman Ltd’s Bristol-Myers Squibb BMY Stock Holding History

Jay A. Fishman Ltd’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-28,377
Closed -$1.97M – 99
2023
Q1 		$1.97M Sell
28,377
-75,120
-73% -$5.3M 0.25% 37
2022
Q4 		$7.45M Sell
103,497
-460
-0.4% -$34.7K 1.05% 20
2022
Q3 		$7.39M Sell
103,957
-650
-0.6% -$47.2K 1.07% 20
2022
Q2 		$8.05M Sell
104,607
-1,150
-1% -$87.6K 1.1% 20
2022
Q1 		$7.72M Buy
105,757
+3,522
+3% +$236K 0.85% 21
2021
Q4 		$6.37M Sell
102,235
-725
-0.7% -$42.5K 0.68% 24
2021
Q3 		$6.09M Buy
102,960
+225
+0.2% +$14.8K 0.75% 22
2021
Q2 		$6.86M Buy
102,735
+27,965
+37% +$1.82M 0.84% 22
2021
Q1 		$4.72M Buy
74,770
+19,800
+36% +$1.23M 0.64% 25
2020
Q4 		$3.41M Buy
54,970
+600
+1% +$36.9K 0.47% 33
2020
Q3 		$3.28M Buy
54,370
+49,570
+1,033% +$2.98M 0.52% 30
2020
Q2 		$282K Buy
+4,800
New +$287K 0.05% 74

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Jay A. Fishman Ltd's BMY Position: Q2 2023 in Review

Jay A. Fishman Ltd sold out of Bristol-Myers Squibb (BMY) in Q2 2023, closing a stake of 28,377 shares — an estimated $1.97M sold.

Jay A. Fishman Ltd first reported a position in BMY in Q2 2020 and held it in 12 quarters. The position peaked at $8.05M in Q2 2022. 2,482 funds tracked by Wall St. Rank hold BMY as of Q2 2023.

  • Jay A. Fishman Ltd reported no remaining Bristol-Myers Squibb position as of Q2 2023 after selling out during the quarter.
  • Jay A. Fishman Ltd sold 28,377 Bristol-Myers Squibb shares in Q2 2023, an estimated $1.97M.
  • Jay A. Fishman Ltd first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 12 quarters.
  • Jay A. Fishman Ltd's Bristol-Myers Squibb position peaked at $8.05M in Q2 2022.
  • 2,482 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2023.

Based on Jay A. Fishman Ltd's 13F filing for Q2 2023, filed 15 Aug 2023.